title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday,20220815T074324,https://www.benzinga.com/news/22/08/28488766/why-embark-technology-jumped-around-85-here-are-108-biggest-movers-from-friday,ZEAL,0.033942,Neutral,-0.129786
71 Biggest Movers From Yesterday,20220520T082731,https://www.benzinga.com/news/22/05/27318002/71-biggest-movers-from-yesterday,ZEAL,0.055946,Neutral,0.080252
"The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation",20220517T130455,https://www.benzinga.com/general/biotech/22/05/27249090/the-daily-biotech-pulse-pfizer-biontechs-covid-19-booster-for-5-11-year-kids-soon-ultragenyx-in-l,ZEAL,0.08978,Neutral,0.009211
"The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More",20220512T124254,https://www.benzinga.com/general/biotech/22/05/27161064/the-daily-biotech-pulse-bristol-myers-bridgebio-ink-oncology-pact-fda-nod-for-lava-therapeutics-b,ZEAL,0.080525,Neutral,-5.2e-05
